Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo

Background: Intravenous (IV) iron is widely used to treat anemia in chronic kidney disease patients. Previously, iron formulations were shown to induce immune activation in-vitro. The current study aimed to investigate the effect of IV iron on complement activation in-vivo, and whether this subseque...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Faria, Bernardo, Gaya da Costa, Mariana, Poppelaars, Felix, Franssen, Casper F. M., Pestana, Manuel, Berger, Stefan P., Daha, Mohamed R., Gaillard, Carlo A. J. M., Seelen, Marc A.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6712170/
https://ncbi.nlm.nih.gov/pubmed/31497011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01885
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires